Tag Archives: dementia

Supporting excellent biomedical science in Europe

The first FEAM European Biomedical Policy Forum annual lecture took place in Brussels, in March, dedicated to the topic Biomedical and health research: developing a vision for Europe.

The Forum is an initiative from the Federation of European Academies of Medicine (FEAM) and aims to bring together representatives from academia, research charities, industry, European and national trade associations and professional bodies, regulators, public health bodies, and patient and consumers groups. Among the topics discussed were: thematic priorities for future research; linkage with the UN Sustainable Development Goals (SDGs); research missions; current gaps in support; and how to improve coordination and consolidation of research programmes across Europe.

This  is  an  important  time  for  European  health  policy  and  for  sustaining  biomedical  research  and innovation. The forthcoming EU Framework Programme for Research and Innovation, FP9, provides a critical opportunity for stakeholders across the biomedical and health sectors to discuss their research vision and priorities for Europe, linkage with global goals, and defining approaches to closing gaps in support and to promoting coordination of effort. Continue reading

Brain Prize winner emphasises essential need for animal research into Alzheimer’s

Basic researchers into Alzheimer disease awarded major scientific prize

Today it was announced that the 2018 Brain Prize will be awarded to Bart De Strooper (VIB, KU Leuven and University College London), Michel Goedert (University of Cambridge), Christian Haass (DZNE, Ludwig-Maximilians-University) and John Hardy (UCL) for their groundbreaking research on the genetic and molecular basis of Alzheimer’s disease.

The four researchers will share the 1 million EUR prize awarded by the Lundbeck Foundation.
This year’s Brain Prize winners have made essential contributions, in basic research, to the genetic and molecular knowledge of Alzheimer’s, mapping new avenues for the diagnosis, treatment and possibly even prevention of this neurodegenerative disorder. Alzheimer’s disease is the most common cause of dementia, affecting approximately 30 million people worldwide. Continue reading